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Introduction
I
nfection  with  hepatitis  B  virus ( HBV)  and 
hepatitis  C  virus ( HCV)  is  a  problem  of 
worldwide  significance  (1).  While  hepatitis  B  is 
vaccine-preventable  (2),  HCV  infection  has  no 
effective vaccine (3). According to a World Health 
Organization (WHO) estimate, two billion people 
in the world have serological evidence of prior HBV 
infection (4), and up to 3% (170 million) are infected 
with HCV (5). HBV and HCV can lead to cirrhosis 
and hepatocellular carcinoma (6). HCV is a leading 
cause of end-stage liver disease and the most common 
indication  for  liver  transplantation  (2).  Although 
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Background and Aims: Health care workers (HCWs) are at risk of contracting and spreading hepatitis B virus (HBV) and 
hepatitis C virus (HCV) to others. The aim of this study was to evaluate knowledge, attitudes and behavior of physicians 
concerning HBV and HCV.
Methods: A 29-item questionnaire (reliability coefficient = 0.7) was distributed at two national/regional congresses and 
two university hospitals in Iran. Five medical groups (dentists, general practitioners, paraclinicians, surgeons and inter-
nists) received 450 questionnaires in 2009, of which 369 questionnaires (82%) were filled out.
Results: Knowledge about routes of transmission of HBV and HCV, prevalence rate and seroconversion rates secondary 
to a needlestick injury was moderate to low. Concern about being infected with HBV and HCV was 69.4±2.1 and 76.3±2 
(out of 100), respectively. Complete HBV vaccination was done on 88.1% of the participants. Sixty percent had checked 
their hepatitis B surface antibody (anti-HBs), and 83.8% were positive. Only 24% of the surgeons often used double 
gloves and 28% had reported a needlestick. There was no significant correlation between the different specialties and: 
concern about HBV and HCV; the underreporting of needlestick injuries; and correct knowledge of post-needlestick HBV 
infection.
Conclusions: Although our participants were afraid of acquiring HBV and HCV, knowledge about routes of transmission, 
prevalence, protection and post-exposure seroconversion rates was unsatisfactory. By making physicians aware of possible 
post-exposure prophylaxis, the underreporting of needlestick injuries could be eliminated. Continuous training about HBV 
and HCV transmission routes, seroconversion rates, protection, as well as hepatitis B vaccination and checking the anti-HBs 
level, is a matter of necessity.
Keywords: Hepatitis B, Hepatitis C, Health Knowledge, Attitudes, Practices,  IranHepatitis Monthly, Summer 2010; 10(3): 176-182
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HCV has been less prevalent since the 1990s in the 
western world, it is still endemic in some African and 
Asian countries (6).
Of the world’s carriers of HBV, 75% are from 
Asia  (2),  and  Iran  represents  a  low-to-  moderate 
category (7). Our recent systematic reviews in Iran 
between  2001  and  2007  found  a  prevalence  of 
HBV and HCV of 2.14% and 0.16%, respectively 
(7,  8).  Iranian  studies  show  that  1.3  to  8.69%  of 
the population are chronic HBV carriers  (9). The 
epidemiology of infection is also changing from a 
vertical to a horizontal route (10). HBV prevalence 
has decreased dramatically in Iran, and it is classified 
as of low endemicity now. This may be due to an 
improvement  of  people’s  knowledge  of  HBV  risk 
factors,  the  national  vaccination  program,  since 
1993, for all neonates, and the vaccination of high-
risk groups (10). Coverage reached 94% by 2005 (10). 
Although there is no mandatory HBV vaccination for 
health care workers (HCWs) in Iran, it is mandatory 
for neonates and adolescents.
HBV  and  HCV  have  common  routes  of 
transmission,  such  as  occupational  exposure 
among HCWs, unprotected sexual contact, vertical 
transmission, intravenous drug use (11, 12) or through 
blood products and contamination during medical 
procedures (2).
The prevalence of hepatitis C is remarkable in 
high-risk groups such as thalassemics (13), intravenous 
drug  users  (2),  and  chronic  hemodialysis  patients 
(11).
For the most part, surgeons in the United States 
(1998) seldom reported needlestick injuries and rarely 
used  double  gloves  (14).  Another  study  indicated 
that  4%  and  61%  of  HCWs,  respectively,  were 
unaware that HBV and HCV can be transmitted by 
needlestick injuries (15).
Iranian midwifery students and graduates (16) and 
surgeons (17) had an undesirable level of knowledge 
of HBV (16). However, dentists were found to have a 
good knowledge of HBV (18).
It is notable that some other studies in Iran had 
evaluated knowledge or behavior of groups other than 
HCWs, or physicians, in dealing with HBV (19, 20). 
Few studies have investigated hepatitis C specifically 
in Iran. Despite the decrease in HBV prevalence in 
our country, there has been no decrease in hepatitis 
C (2).
It  has  been  demonstrated  that  patient  medical 
histories  are  unreliable  in  identifying  exposure  to 
HBV infection  (17). The needlestick injuries are a 
personal, legal and professional hazard to HCWs, 
physicians  and  their  patients  (21).  As  hepatitis  B 
and C can lead to much morbidity and mortality, 
and  physicians  and  other  medical  specialists  are 
a  high-risk  group  for  acquiring  HBV  and  HCV 
infection and for transmission to their patients and 
close contacts, it makes sense to evaluate physicians’ 
knowledge, attitudes and practice not only towards 
HBV transmission and protection, but also towards 
HCV, to which little attention has yet been paid.
Materials and Methods
Questionnaire
We  designed  a  29-item  self-administered 
questionnaire  assessing  risk  of  transmission; 
seroconversion rates; the actual prevalence of HBV 
and  HCV  in  Iran;  vaccination  against  HBV;  use 
of  double  gloves,  and  protective  eyewear;  rate  of 
needlestick injury and its report; checking the status 
of  viral  hepatitis;  using  disposable  syringes  and 
discarding  them;  and  post-exposure  prophylaxis. 
It consisted of use of the likert scale; yes/no and a 
few  open-ended  questions,  in  addition  to  some 
demographics  (age,  gender,  specialty,  work  time 
per week). For validating the questionnaire, some 
physicians,  expert  in  standardizing  questionnaires, 
confirmed  the  face  and  content  validity  of  the 
primary  questionnaire,  and  some  questions  were 
omitted according to their comments. According to 
our pilot study on 60 randomly selected physicians, 
the reliability coefficient of the questionnaire was 0.7, 
using Cronbach’s alpha. The reliability coefficients 
of each of the three parts of the questionnaire for 
knowledge, attitude and practice issues were 0.65, 
0.75, and 0.67. The Ethical Committee of Baqyitallah 
Research  Center  for  Gastroenterology  and  Liver 
Disease, Tehran, Iran approved the proposal.
Samples
We distributed questionnaires among participants 
in two viral hepatitis congresses in advance, in Tehran 
(capital  of  Iran,  a  national  congress)  and  in  Zanjan 
(in western Iran, a regional congress) and also among 
physicians  of  two  university  hospitals  in  Ahvaz  (in 
southern  Iran).  Participants  retuned  370  (82%)  of 
the 450 distributed questionnaires. We excluded one 
questionnaire due to its missing more than 50% of the 
data. Considering our previous paper about a Knowledge, 
attitudes and practice (KAP) survey concerning blood-
borne diseases in surgeons (17), we estimated that the 
average percentage of physicians with a sufficient score 
for all knowledge, attitudes and practices was about 
19%. We used a rate-estimation formula for calculating 
sample size, while we assumed the precision of this 
ratio to be 0.04% and type-one error equal to 0.05. 
Considering a response rate of almost 80%, the total 
sample size was calculated as 450.Hepatitis Monthly, Summer 2010; 10(3): 176-182
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In  this  cross  sectional  study,  we  considered 
dentists, general practitioners (GPs), paraclinicians 
(laboratory specialists, pathologists, anesthesiologists, 
radiologists,  and  parasitologists),  surgeons 
(gynecologists,  general  surgeons,  and  orthopedic 
surgeons)  and  internists  (internal  medicine 
specialists,  pediatricians,  cardiologists,  infectious 
disease  specialists,  dermatologists,  and  emergency 
medicine specialists) as different groups.
Data Analysis
We used mean±SE (standard error), t-test, one 
way  ANOVA  with  post  hoc,  Kruskal-Wallis,  and 
chi-square in analysis by SPSS 13 software (SPSS 
Inc. Chicago, Illinois, USA). The authors considered 
differences  and  correlations,  with  P  <  0.05  as 
statistically significant.
Results
Of  369  participants  who  returned  completed 
forms, 13 cases were not active in medical practice. 
Therefore, analysis was done on the 356 remaining 
cases, with 166 (46.6%) women, 157 (44.1%) men 
and 33 (9.3%) who did not state their gender. They 
had a mean age of 41.1±.5 (range: 25-79) years, a 
median duration in medical practice of 12 (range: 
0.3-50) years, and a median weekly medical practice 
of 35 (range: 2-120) hours. Of participants, 36.3% 
were employees of university hospitals and clinics 
of the Ministry of Health, 39.8% worked in private 
practice, and 23.9% worked in both private practice 
and as employees of clinics and university hospitals.
Only  44.9%  were  aware  that  viral  hepatitis  B 
and C can be transmitted from patients to patients, 
dentists to patients and vice versa. Others believed 
that at least one of these routes could not be a possible 
risk of transmission.
Knowledge
Participants estimated that 11.3±1.1 and 8.9±1.4 
of their patients were positive for HBV and HCV, 
respectively.
Knowledge  about  HBV  and  HCV  routes  of 
transmission, prevalence rate and seroconversion rates 
secondary to a needlestick injury was unsatisfactory 
(Table  1).  Most  participants  were  not  aware  and 
most  of  them  underestimated  the  seroconversion 
rates, post-exposure to HBV or HCV.
According to table 1, 47.2% versus 66.9% had 
a  correct  estimation  of  HCV  (<1%)  and  HBV 
(>1%)  prevalence,  respectively.  However,  2.8% 
of  our  participants  estimated  HCV  prevalence  in 
their patients correctly (between 0.1-0.3%), 1.1% 
underestimated it (<0.1%), 47.2% overestimated it 
(>0.3%), and 48.9% had no idea. These percentages 
were 14.3% (correct answer; between 2-3%), 13.8% 
(underestimated;  <2%),  36.5%  (overestimated;  > 
3%), and 35.4% (no idea) for HBV.
Attitudes
Participants requested HBV and HCV screening 
tests  for  30.1±2.5  and  20.9±2.6  percent  of  their 
patients, respectively.
Concern  about  being  infected  with  HBV  and 
HCV was 69.4±2.1 and 76.3±2 (of 100 total score), 
respectively.
Practice
Among 61.3% who did surgical procedures, only 
24% often, and none always, used double gloves; 
while  43.8%  of  them  always  used  glasses  and/or 
masks.
Complete  vaccination  against  hepatitis  B  was 
done on 88.1% of the participants. In addition, 8.1% 
had insufficient vaccination (less than 3 times), and 
3.9% of them were in process. Merely 60% of the 
participants (210 cases) had checked their hepatitis 
B surface antibody (anti-HBs) level, of whom 83.8% 
were positive.
Of the participants, 3.6% did not use discarded 
syringes. Rate of covering (always or often) the needle 
before discard was 73.4%.
While 52.1% had scratches, ulcers or open wounds 
on their hands most of the time (sometimes, often 
and always) and 47.1% had at least one needlestick 
per year, just 28% had always/often reported their 
actual needlestick injury and 40% did not.
They had experienced 1.9±.4 times needlestick 
injuries over the last 3 years and were stuck by a 
needle while treating a patient positive for HBV and 
HCV in 5.1% and 1.2% of cases, respectively.
Contamination of their eyes and mucosa by the 
secretions of a patient positive for HBV and HCV was 
reported by 3.7% and 0.8% of them, respectively.
Nearly  all  cases  with  the  reported  needlestick 
injury had been treated with hepatitis B vaccine and/
or immunoglubolin.
Completion  of  vaccination  was  strictly  related 
to  participants’  knowledge  about  viral  hepatitis 
prevalence. Those who were not vaccinated against 
HBV had a significantly falsely higher estimation of 
HBV (55.9±7.4 vs. 39.6±2.5, P = .043) and HCV 
(72.6±6.9 vs. 49.6±2.7, P = .003) infection in their 
patients.
Specialty-related analysis
Dentists and general practitioners were younger 
and less experienced in comparison with paraclinicians Hepatitis Monthly, Summer 2010; 10(3): 176-182
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Discussion
In the present study, different medical specialties 
overestimated  the  prevalence  of  HBV-  and  HCV-
infected  patients,  while  most  protection  measures 
were  underutilized  by  them.  Knowledge  of  the 
correct transmission route of HBV and HCV was 
unsatisfactory  in  most  of  the  participants.  Our 
study indicates that dentists had a better knowledge 
of HBV transmission via saliva in comparison with 
the other specialists. Interestingly, those who were 
not vaccinated against HBV had significantly falsely 
higher estimation of HBV and HCV infection in their 
patients, which demonstrate that fear is not enough to 
ensure the taking of protective measures. This finding 
is in concordance with a recent study among Iranian 
surgeons on blood-borne pathogens (17).
In the present study, a high percentage of complete 
vaccination against hepatitis B could explain a non-
significant correlation between vaccination and most 
of the variables. The fact that general practitioners 
and surgeons checked their anti-HBs level the least 
is a matter of great concern. In our previous study, 
76% of the surgeons had undergone complete HB 
vaccination  (17), while in the present study it had 
increased to 94.7%, although the checking of anti-
HBs level has not progressed significantly  (17). As 
general practitioners were the busiest of all, we may 
attribute this lack of concern to their workload. In 
an Italian survey, the majority of dentists were not 
immunized against HBV, because 42.8% considered 
it useless and 33.3% unsafe  (25). Fortunately, our 
study does not support this data. In another study, 
vaccination  against  HBV  was  done  in  94.9%  of 
dentists with complete vaccination in 74.8% of them 
and only 47.9% of them have been checked for HBV 
antibodies after vaccination (26). These figures in our 
study have increased to 100% and 75%, respectively 
(Table 2).
It  is  notable  that  even  in  dentists  with  100% 
coverage of HBV vaccination in our study, a positive 
titer of anti-HBs level was not satisfactory. Therefore, 
checking post-vaccination anti-HBs level should be 
mandatory  and  subjects  with  low  anti-HBs  levels 
measured at least one month after their last vaccine 
dose (< 10 mIU/mL), with a negative result of both 
hepatitis B surface antigen (HBsAg), and hepatitis 
B  core  antibody  (anti-HBc)  considered  as  non-
responders (24) and followed.
Participants requested more HBV screening tests 
for their patients. It is obvious that our participants as 
medical specialists took HCV less seriously. Notably, 
surgeons requested more lab screening tests for their 
patients. 
Although  the  use  of  double  gloves  can  help 
ensure better protection as a second barrier (27), in a 
recent study in Iran, 12.9% of surgeons always used 
double gloves (17) and in a study in the United States, 
surgeons rarely used double gloves (14). 
In our study, double gloves were used by 33% of 
surgeons, which is a sign of positive progress, although 
it  is  certainly  not  enough.  Reports  from  several 
countries indicate that some dentists do not engage in 
safe practices, especially in wearing gloves, facemasks, 
or protective eye glasses  (26). In the present study, 
dentists are more used to wearing double gloves than 
others (Table 2), although statistically no significant 
difference exists between surgeons and dentists in the 
use of double gloves. The probability of acquiring 
a  blood-borne  infection  following  occupational 
exposure, depending on the body fluid involved, and 
the infectivity of the patient, has been estimated at 
0.5% for HCV, and 18%-30% for HBV (24).
In comparison with HCV, HBV prevalence was 
better known to our participants. (Table 1). Although 
disappointingly  most  of  our  participants  did  not 
know the correct percentage of seroconversion rate, 
secondary to a HBV and HCV needlestick injury 
(Table 2) even if 5.1% and 1.2%, respectively, of 
the participants mentioned that they had been stuck 
by  a  needle  while  treating  a  patient  positive  for 
HBV and HCV, and they also under reported these 
injuries. This underscores the depth and seriousness 
of the problem in the health system as to the high 
seroconversion rate of HBV and the lack of available 
vaccination for HCV (24).
Actually, it is almost a worldwide issue, as other 
studies  show  that  nearly  80%  of  surgeons  never, 
or rarely, report needlestick injuries (27-31) as well. 
Surgeons  do  not  usually  report  their  needlestick 
injuries  (17).  Unfortunately,  contamination  of 
physicians’ eyes and mucosa by the secretions of a 
patient positive for HBV and HCV was only reported 
by 3.7% and 0.8% of physicians, respectively, which 
may be due to lack of sufficient knowledge about 
possible post-exposure prophylaxis, or to their lack 
of interest in their own self preservation.
Complete  vaccination  and  anti-HBs  titer 
checking should be a must for all HCWs including 
medical specialists; and issuing a special card noting 
the number of vaccination shots and the last anti-
HBs titer seems wise. As our participants’ health is 
not simply a matter of their own concern; but their 
infection with HBV and HCV can be dangerous 
for others, so their reeducation for both HBV and 
HCV  prevention,  seroconversion  rates  and  the 
importance  of  reporting  their  needlestick  injuries 
should be of paramount concern. Recommending 
usage of double gloves and eye protection is a good 
and easily modifiable behavior (22, 23) and HCWs Hepatitis Monthly, Summer 2010; 10(3): 176-182
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must be aware of first aid to meet the post-exposure 
needs  as  follows:  for  percutaneous  exposure, 
encourage bleeding and wash with soap and water; 
for cutaneous contamination, wash with soap and 
water; for mucous membrane contamination, flush 
with water. Eyes should be irrigated with clean water, 
saline, or sterile irrigants (24).
HCWs including physicians should be informed 
of the medicolegal and clinical relevance of reporting 
an  exposure,  and  they  must  have  rapid  access  to 
expert  consultants  for  treatment  and  follow-up. 
The  management  of  an  occupational  exposure  to 
HBV differs according to the susceptibility of the 
exposed  HCWs  and  the  serostatus  of  the  source. 
When  indicated,  post-exposure  prophylaxis  with 
HBV vaccine, hepatitis B immunoglobulin or both 
must be started as soon as possible (within 1-7 days). 
In  the  absence  of  prophylaxis  against  hepatitis  C 
virus  (HCV)  infection,  follow-up  management  of 
HCV exposure depends on which type of antiviral 
treatment during the acute phase is chosen (24).
We  recommend  observing  the  behavior  of 
physicians  and  other  HCWs  toward  an  HBV-  or 
HCV-infected patient in future studies as unfriendly 
behavior may cause patients to conceal the truth, 
leading to unwanted spread of disease.
We  also  recommend  that  the  production  of 
undisposable syringes be stopped in order to prevent 
unintentional  reusage  of  syringes  by  HCWs  and 
intentional reusage by IV drug abusers.
There were a few limitations and probably a few 
confounding factors in this study. For instance we 
cannot conclude that dentists avoid requesting HBV 
and HCV lab tests for their suspected patients, as their 
other behavior does not support this hypothesis. We 
believe that such a trend might be attributed to lack 
of insurance company support. We suggest that the 
health system should encourage insurance companies 
to provide for lab tests requested by dentists too.
Conclusions
Although our participants were medical specialists 
in various fields and were afraid of acquiring HBV and 
HCV, their knowledge about routes of transmission, 
prevalence,  protection  and  post-exposure 
seroconversion rates of both HBV and HCV was 
unsatisfactory. As our participants’ health is not just 
their own concern and their possible infection and 
underestimation of HBV and HCV infection could 
be a threat for their patients, their close contacts and 
society,  more  thoroughgoing  education  is  needed. 
Providing post-exposure prophylaxis facilities could 
also increase the reporting of needlestick injuries.
This study indicates that our medical specialists 
are not alert enough to HBV and HCV. They must 
be sufficiently well informed to be able to improve 
knowledge, attitudes and behavior of other HCWs 
and patients. It also seems evident that additional 
research on HCV is needed in this regard.
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